(Circulation. 1999;100:924-932.)
© 1999 American Heart Association, Inc.
Clinical Investigation and Reports |
From the Division of Cardiovascular Pathophysiology, The Joan and Sanford I. Weill Medical College of Cornell University, The New York Presbyterian HospitalWeill Cornell Medical Center, New York, NY.
BackgroundPrevious data indicate that left ventricular ejection fraction (LVEF) provides prognostic information among patients with coronary artery disease (CAD), but the value of such testing specifically for defining benefits of coronary artery bypass grafting (CABG) may relate to severity of exercise-inducible ischemia measured noninvasively before surgery.
Methods and ResultsTo determine the independent prognostic
importance of preoperative ischemia severity for predicting
outcomes of CABG among patients with extensive CAD, we monitored 167
stable patients with angiographically documented 3-vessel CAD (average
follow-up of 9 years in event-free patients) who previously had
undergone rest and exercise radionuclide cineangiography. Their course
was correlated with data obtained during initial radionuclide testing,
coronary arteriography, and clinical evaluation at study entry.
Fifty-two patients received medical treatment only, and 115 underwent
CABG (44 early [
1 month after initial study]).
Multivariate Cox model analysis indicated that
change (
) in LVEF from rest to exercise during radionuclide study
was the strongest independent predictor of major cardiac events
(P=0.003) before surgery and also predicted magnitude of
CABG benefit (P=0.04). Patients with
LVEF -8% or
less derived significant survival-prolonging and event-reducing benefit
from CABG performed
1 month after initial testing
(P<0.02 for cardiac death and P=0.008
for cardiac events], early CABG versus medical-treatment-only
patients); similar benefits were absent among patients with
LVEF
more than -8%, and among those in whom CABG was deferred.
ConclusionsAssessment of ischemia severity based on LVEF response to exercise enables effective prognostication among patients with 3-vessel CAD and defines the likelihood of life-prolonging and event-reducing benefits from CABG.
Key Words: prognosis ischemia coronary disease grafting
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1999 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |